| Date Filed | Type | Description |
| 03/28/2023 |
25
| Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities: |
| 03/09/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/02/2023 |
PRER14A
| Form PRER14A - Preliminary Proxy Soliciting materials: |
| 02/27/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 02/27/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/27/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/27/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/27/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/27/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/27/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/22/2023 |
RW
| Form RW - Registration Withdrawal Request: |
| 02/22/2023 |
8-K
| Quarterly results |
| 02/14/2023 |
SC 13G/A
| Flagship VentureLabs IV, LLC reports a 42.7% stake in Rubius Therapeutics, Inc. |
| 02/09/2023 |
SC 13G/A
| FMR LLC reports a 13.7% stake in RUBIUS THERAPEUTICS INC |
| 02/06/2023 |
8-K
| Quarterly results |
| 01/20/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/21/2022 |
8-K
| Quarterly results |
| 12/14/2022 |
8-K
| Quarterly results |
| 12/12/2022 |
8-K
| Quarterly results |
| 11/09/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/02/2022 |
8-K
| Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm... |
| 10/17/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/13/2022 |
8-K
| Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran... |
| 09/13/2022 |
8-K
| Cost Associated with Exit or Disposal Activities, Other Events, Financial Statements and Exhibits Interactiv... |
| 08/12/2022 |
8-K
| Quarterly results |
| 08/09/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/09/2022 |
8-K
| Quarterly results |
| 08/01/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 07/14/2022 |
8-K
| Quarterly results |
| 07/07/2022 |
8-K
| Quarterly results |
| 06/24/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 06/22/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/08/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 06/08/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
|